Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 30, 2015 10:26 AM ET

Pharmaceuticals

Company Overview of Allergan plc

Executive Profile

Brenton L. Saunders J.D.

Chief Executive Officer, President and Director, Allergan plc
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 12 different industries.

See Board Relationships
45$36,613,829
As of Fiscal Year 2014

Background

Mr. Brenton L. Saunders, also known as Brent, J.D., has been the Chief Executive Officer and President of Allergan plc since July 1, 2014. Mr. Saunders served as the Chief Executive Officer and President of Forest Laboratories Inc from October 1, 2013 to 2014. He served as an Advisor of Valeant Pharmaceuticals International, Inc. since August 2013. He served as Senior Vice President of Compliance, Legal and Regulatory at HomeCare America. He served as the Chief Executive ...

Corporate Headquarters

Morris Corporate Center III
Parsippany, New Jersey 07054

United States

Phone: 862-261-7000
Fax: --

Board Members Memberships

Director
Director
2014-Present
Chief Executive Officer, President and Director

Education

BA
University of Pittsburgh
JD
Temple University School Of Law
MBA
Fox School of Business and Management Temple University in Philadelphia

Other Affiliations

Annual Compensation

Salary$500,000
Total Annual Compensation$500,000

Stocks Options

Restricted Stock Awards$25,931,824
All Other Compensation$55,187
Exercisable Options$89,503
Unexercisable Options$317,599
Total Number of Options$407,102

Total Compensation

Total Annual Cash Compensation$2,096,437
Total Short Term Compensation$500,000
Other Long Term Compensation$25,987,011
Total Calculated Compensation$36,613,829
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Lars Rebien Sørensen Chief Executive Officer, President and Member of Executive Management
Novo Nordisk A/S
$15.2M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Allergan plc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.